Hermine BrunnerAt.Cincinnati Children's, Dr. Brunner leads the Division of Rheumatology, where she and her team integrate clinical and translational research into daily care. Her research at Cincinnati Children's is focused on the development of clinical trial endpints, surrogate measures and biomarkers as they pertain to pediatric rheumatic diseases, particularly lupus. She conducts clinical trials in pediatric rheumatic disease, drug development, and biomarker discovery for lupus nephritis and lupus that affects the brain. As part of her investigator-initiated research, she has successfully conducted several large multinational studies to develop flare, improvement, remission and inactive disease criteria for children with lupus. Dr. Brunner serves as the scientific director of the Pediatric Rheumatology Collaborative Study Group, where she works alongside researchers at more than 80 academic centers across the U.S. and Canada. Her personal affiliations include the Childhood Arthritis and Rheumatology and Research Alliance and the American College of Rheumatology. She has received the Castle Connolly Regional Top Doctor and Exceptional Women in Medicine awards (2017, 2018 and 2019), the Halsted R. Holman Award for Excellence in Clinical Research (2018), and the Above & Beyond Doctor of the Year award from the Aubrey Rose Foundation (2018). Read More Read Less